Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome

Journal of Pediatrics

Volumn 158, Issue 2, 2011, Pages 337-339

  Paz Priel, Ido ^a   Cooke, David W ^a   Chen, Allen R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB;

ARTICLE; AUTONOMIC DYSFUNCTION; CANCER SURGERY; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HUMAN; HYPOTHALAMUS DISEASE; HYPOVENTILATION; IMMUNOSUPPRESSIVE TREATMENT; NEUROBLASTOMA; NEUTROPENIA; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL;

ACUTE DISEASE; ADRENAL GLAND NEOPLASMS; AUTONOMIC NERVOUS SYSTEM DISEASES; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHALAMIC DISEASES; IMMUNOSUPPRESSIVE AGENTS; OBESITY; OBESITY HYPOVENTILATION SYNDROME; PULSE THERAPY, DRUG; SEVERITY OF ILLNESS INDEX; SYNDROME; TREATMENT OUTCOME;

EID: 78651470439     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.07.006     Document Type: Article

References (13)

1. P. Bougneres, L. Pantalone, A. Linglart, A. Rothenbuhler, and C. Le Stunff Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood J Clin Endocrinol Metab 93 2008 3971 3980
2. L. De Pontual, D. Trochet, S. Caillat-Zucman, O.A. Abou Shenab, P. Bougneres, and Y. Crow Delineation of late-onset hypoventilation associated with hypothalamic dysfunction syndrome Pediatr Res 64 2008 689 694
3. D. Ize-Ludlow, J.A. Gray, M.A. Sperling, E.M. Berry-Kravis, J.M. Milunsky, and I.S. Farooqi Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood Pediatrics 120 2007 e179 e188
4. N. Sirvent, E. Berard, P. Chastagner, F. Feillet, K. Wagner, and D. Sommelet Hypothalamic dysfunction associated with neuroblastoma: evidence for a new paraneoplastic syndrome? Med Pediatr Oncol 40 2003 326 328
5. E.S. Katz, S. McGrath, and C.L. Marcus Late-onset central hypoventilation with hypothalamic dysfunction: a distinct clinical syndrome Pediatr Pulmonol 29 2000 62 68
6. K.N. North, R.A. Ouvrier, C.A. McLean, and I.J. Hopkins Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: report of two cases J Child Neurol 9 1994 320 325
7. R. Ouvrier, K. Nunn, T. Sprague, C. McLean, S. Arbuckle, and I. Hopkins Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome? Lancet 346 1995 1298
8. R.A. Brodsky High-dose cyclophosphamide for autoimmunity and alloimmunity Immunol Res 47 2010 179 184
9. R.A. Brodsky, and R.J. Jones Intensive immunosuppression with high-dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages Autoimmunity 41 2008 596 600
10. D.B. Drachman, and R.A. Brodsky High-dose therapy for autoimmune neurologic diseases Curr Opin Oncol 17 2005 83 88
11. M.R. Pranzatelli, E.D. Tate, A.L. Travelstead, J. Barbosa, R.A. Bergamini, and L. Civitello Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome J Pediatr Hematol Oncol 28 2006 585 593
12. K.B. Dussan, L. Magder, R.A. Brodsky, R.J. Jones, and M. Petri High-dose cyclophosphamide performs better than monthly-dose cyclophosphamide in quality of life measures Lupus 17 2008 1079 1085
13. D.L. Weed On the use of causal criteria Int J Epidemiol 26 1997 1137 1141